(Q39000123)

8 September 2017

title

Development of 3-phenyl-N-(2-(3-phenylureido)ethyl)-thiophene-2-sulfonamide compounds as inhibitors of antiapoptotic Bcl-2 family proteins (English)

1 reference

8 September 2017

Chengwen Yang

1

1 reference

8 September 2017

Sha Chen

2

1 reference

8 September 2017

Mi Zhou

3

1 reference

8 September 2017

Yan Li

4

1 reference

8 September 2017

Yangfeng Li

5

1 reference

8 September 2017

Zhengxi Zhang

6

1 reference

8 September 2017

Zhen Liu

7

1 reference

8 September 2017

Qian Ba

8

1 reference

8 September 2017

Jingquan Li

9

1 reference

8 September 2017

Hui Wang

10

1 reference

8 September 2017

Xiaomei Yan

11

1 reference

8 September 2017

Dawei Ma

12

1 reference

8 September 2017

Renxiao Wang

13

1 reference

8 September 2017

publication date

29 April 2014

1 reference

8 September 2017

1 reference

8 September 2017

volume

9

1 reference

8 September 2017

issue

7

1 reference

8 September 2017

page(s)

1436-1452

1 reference

Apoptosis-based therapies

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Promoting apoptosis as a strategy for cancer drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Regulators of apoptosis: suitable targets for immune therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

The genetics of the p53 pathway, apoptosis and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Apoptosis and cancer: the genesis of a research field

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

The Bcl2 family: regulators of the cellular life-or-death switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

BCL-2 family antagonists for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Directing cancer cells to self-destruct with pro-apoptotic receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Small-molecule inhibitors of protein-protein interactions: progressing towards the dream

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Inhibiting protein-protein interactions using designed molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Reaching for high-hanging fruit in drug discovery at protein-protein interfaces

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Rational design and real time, in-cell detection of the proapoptotic activity of a novel compound targeting Bcl-X(L).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Acylpyrogallols as inhibitors of antiapoptotic Bcl-2 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

WL-276, an antagonist against Bcl-2 proteins, overcomes drug resistance and suppresses prostate tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Apogossypol derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Design, synthesis, and interaction study of quinazoline-2(1H)-thione derivatives as novel potential Bcl-xL inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

3-Thiomorpholin-8-oxo-8H-acenaphtho[1,2-b]pyrrole-9-carbonitrile (S1) based molecules as potent, dual inhibitors of B-cell lymphoma 2 (Bcl-2) and myeloid cell leukemia sequence 1 (Mcl-1): structure-based design and structure-activity relationship st

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Quinazoline sulfonamides as dual binders of the proteins B-cell lymphoma 2 and B-cell lymphoma extra long with potent proapoptotic cell-based activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Structure-based design of potent Bcl-2/Bcl-xL inhibitors with strong in vivo antitumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Structure-based discovery of BM-957 as a potent small-molecule inhibitor of Bcl-2 and Bcl-xL capable of achieving complete tumor regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

A potent and highly efficacious Bcl-2/Bcl-xL inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Structure-guided design of a selective BCL-X(L) inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Discovery of potent Mcl-1/Bcl-xL dual inhibitors by using a hybridization strategy based on structural analysis of target proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Rise of the selective inhibitors of anti-apoptotic Bcl-2 family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

The BCL-2 protein family: opposing activities that mediate cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Discovery and development of thiazolo[3,2-a]pyrimidinone derivatives as general inhibitors of Bcl-2 family proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Characterization of the stereochemical structures of 2H-thiazolo[3,2-a]pyrimidine compounds and their binding affinities for anti-apoptotic Bcl-2 family proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

De novo design, synthesis and evaluation of benzylpiperazine derivatives as highly selective binders of Mcl-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Structural insights into the degradation of Mcl-1 induced by BH3 domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

Click-Chemie: diverse chemische Funktionalität mit einer Handvoll guter Reaktionen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.201400058

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CMDC.201400058

1 reference

8 September 2017

1 reference